Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Neoplasms 1 Mesothelioma, Malignant 1 Lymphatic Metastasis 1 Kidney Neoplasms 1 Hemangioma, Capillary 1 Head and Neck Carcinoma 1 Cerebral Hemorrhage 1 Brain Neoplasms 1 Bone Neoplasms 1 Arteriovenous Malformations 1

Interventions

Indocyanine Green 7 Lymph Node Excision 6 Surgical Procedures, Operative 5 Radiotherapy, Intensity-Modulated 4 Radiotherapy 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Cisplatin 4 Specimen Handling 3 gadofosveset trisodium 2 Technetium 2 TP protocol 2 Sentinel Lymph Node Biopsy 2 Radiation Dose Hypofractionation 2 Nivolumab 2 Ipilimumab 2 Electroporation 2 Conversion to Open Surgery 2 Control Groups 2 Chemotherapy, Adjuvant 2 Chemoradiotherapy 2 Artificial Intelligence 2 tislelizumab 1 sarcolipin 1 radium Ra 223 dichloride 1 peposertib 1 pembrolizumab 1 lncRNA LNMAT1, human 1 gewf solution 1 fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphatic Metastasis × Surgery, Computer-Assisted × Clear all

NCT05867095 2023-05-19

N16LND

The Netherlands Cancer Institute

Phase NA Completed

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡